Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Neurodiagnostics Market to Accelerate Substantially at a CAGR of ~7% by 2034 | DelveInsight

globenewswire.com
ABBV AbbVie Inc. is mentioned as a key company in the neurodegenerative disease market, which is a segment of the broader neurodiagnostics market discussed in the article. The article does not provide specific sentiment towards AbbVie. AMRN Amneal Pharmaceuticals, Inc. is listed as a key company in the neurodegenerative disease market. The article does not offer specific sentiment or details about Amneal's performance or prospects. AXSM Axsome Therapeutics, Inc. is mentioned as a key company in the Alzheimer's disease market. The article does not provide specific sentiment or details about Axsome Therapeutics. BMY Bristol Myers Squibb Company is mentioned as a key player in both the neurodegenerative disease market and the Alzheimer's disease market. The article does not provide specific sentiment towards the company. BIIB Biogen Inc. is listed as a key company in the neurodegenerative disease market. The article does not offer specific sentiment or details about Biogen's performance or prospects. BSX Boston Scientific Corporation is mentioned as a key player in the neurodiagnostics market. The article does not provide specific sentiment or details about the company's performance. LLY Eli Lilly and Company is mentioned as a key player in both the neurodegenerative disease market and the Alzheimer's disease market. The article does not provide specific sentiment towards the company. GSK GlaxoSmithKline plc (GSK plc) is listed as a key company in the neurodegenerative disease market. The article does not offer specific sentiment or details about GSK's performance or prospects. JNJ Johnson & Johnson is mentioned as a key company in both the neurodegenerative disease market and the Alzheimer's disease market. The article does not provide specific sentiment towards the company. MDT Medtronic plc is mentioned as a key player in the neurodiagnostics market. The article does not provide specific sentiment or details about the company's performance. NVS Novartis AG is mentioned as a key company in both the neurodegenerative disease market and the Parkinson's disease market. The article does not provide specific sentiment towards the company. NVO Novo Nordisk is listed as a key company in the Alzheimer's disease market. The article does not offer specific sentiment or details about Novo Nordisk's performance or prospects. SNPS Snap Inc. is mentioned indirectly as the parent company of NextMind, a neurotechnology company. The article does not provide specific sentiment towards Snap Inc. itself. SUPN Supernus Pharmaceuticals, Inc. is mentioned as a key company in both the neurodegenerative disease market and the Parkinson's disease market. The article does not provide specific sentiment towards the company. TMO Thermo Fisher Scientific Inc. is listed as a key company in the in vitro diagnostics market. The article does not provide specific sentiment or details about the company's performance. ABT Abbott Laboratories is mentioned as a key player in the neurodiagnostics market and the in vitro diagnostics market. The article does not provide specific sentiment or details about the company's performance. XOM Exxon Mobil Corporation is mentioned in the context of nuclear energy, which is listed as a hot market. However, the article does not provide any specific information or sentiment related to Exxon Mobil's operations or performance.

Global Neurodiagnostics Market to Accelerate Substantially at a CAGR of ~7% by 2034 | DelveInsight New York, USA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Global Neurodiagnostics Market to Accelerate Substantially at a CAGR of ~7% by 2034 | DelveInsight

The neurodiagnostics market is experiencing steady growth, driven by the rising prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, epilepsy, stroke, and multiple sclerosis. Increasing demand for early and accurate diagnosis, coupled with continuous advancements in neuroimaging, electrophysiology, and biomarker-based diagnostic technologies, is accelerating market expansion. The integration of artificial intelligence and machine learning into diagnostic workflows is further improving diagnostic accuracy and efficiency. Additionally, growing healthcare investments, expanding awareness of neurological health, and improved access to advanced diagnostic services are expected to support sustained market growth over the coming years.

DelveInsight’s Neurodiagnostics Market Insights report provides the current and forecast market analysis, individual leading neurodiagnostics companies’ market shares, challenges, neurodiagnostics market drivers, barriers, trends, and key neurodiagnostics companies in the market.

Neurodiagnostics Market Summary

To read more about the latest highlights related to the neurodiagnostics market, get a snapshot of the key highlights @ https://www.delveinsight.com/report-store/neurodiagnostics-market

Key Factors Contributing to the Rise in Growth of the Neurodiagnostics Market

Get a sneak peek at the neurodiagnostics market dynamics @ Neurodiagnostics Market Trends

Regional Neurodiagnostics Market Insights

North America

Europe

Asia-Pacific

To know more about why North America is leading the market growth in the neurodiagnostics market, get a snapshot of the Neurodiagnostics Market Share

Recent Developmental Activities in the Neurodiagnostics Market

What is Neurodiagnostics?

Neurodiagnostics refers to the collection of diagnostic techniques and technologies used to evaluate the structure, function, and health of the nervous system, including the brain, spinal cord, and peripheral nerves. These tools play a crucial role in the early detection, diagnosis, monitoring, and management of neurological disorders such as epilepsy, stroke, Parkinson’s disease, Alzheimer's disease, multiple sclerosis, neuropathies, and traumatic brain injuries. Neurodiagnostic procedures include electrophysiological tests such as electroencephalography (EEG), electromyography (EMG), nerve conduction studies (NCS), and evoked potentials (EP), as well as advanced neuroimaging modalities like magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET). With continuous advancements in imaging technology, artificial intelligence, and portable diagnostic systems, neurodiagnostics is becoming increasingly accurate, accessible, and essential for enabling timely clinical decision-making and improving patient outcomes.

Neurodiagnostics Market Assessment

Which MedTech key players in the neurodiagnostics market are set to emerge as the trendsetter explore @ Neurodiagnostics Market Analysis

Table of Contents

Interested in knowing the neurodiagnostics market share by 2034? Click to get a snapshot of the Neurodiagnostics Market Size

Related Reports

Neurotechnology Market

Neurotechnology Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key neurotechnology companies such as Neuralink Corp., Synchron Inc., Paradromics Inc., Blackrock Neurotech LLC, Kernel Inc., Emotiv Inc., NeuroSky Inc., OpenBCI Inc., Neurable Inc., BrainCo Inc., NextMind (Snap Inc.), Bitbrain Technologies S.L., Advanced Brain Monitoring Inc., Cognionics Inc., g.tec medical engineering GmbH, Natus Medical Incorporated, Nihon Kohden Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, and others.

Neurodegenerative Disease Market

Neurodegenerative Disease Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key neurodegenerative disease companies such as Eisai Co., Ltd., AbbVie Inc., Johnson & Johnson, Novartis AG, Biogen Inc., Eli Lilly and Company, Amneal Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc (GSK plc), H. Lundbeck A/S, Supernus Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Mitsubishi Tanabe Pharma Corporation, Neurocrine Biosciences, Inc., PTC Therapeutics, Inc., and others.

In Vitro Diagnostics Market

In Vitro Diagnostics Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key in vitro diagnostics companies such as F. Hoffmann-La Roche Ltd, Abbott, FUJIFILM Corporation, Sysmex Corporation, Siemens Healthcare GmbH, BD, Seegene Inc, Beckman Coulter, Inc ( Danaher Corporation), QIAGEN, bioMérieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc, Cisbio (PerkinEemer), ARKRAY, Inc, Ortho Clinical Diagnostics, ACON Laboratories, Inc., Teco Diagnostics, EKF Diagnostics, Besurence GmbH, Savyon Diagnostics, HORIBA, Ltd., Palliance AB, Sugentech, Inc, Cypress Diagnostics, Salignostics, The Menarini Group, DxGen Corp, HUMAN, Nova Biomedical, Asahi Kasei Pharma Corporation, Agilent Technologies, Inc., and others.

Alzheimer's Disease Market

Alzheimer's Disease Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Alzheimer's disease companies, including Novo Nordisk, Eli Lilly, Suven Life Sciences, Bristol Myers Squibb, IGC Pharma, T3D Therapeutics, Lexeo Therapeutics, Axsome Therapeutics, Araclon Biotech S.L., Eisai, TauRx Therapeutics, GemVax & KAEL, AC Immune SA, Johnson & Johnson, Longeveron, Vaccinex, Sinaptica Therapeutics, and others.

Parkinson’s Disease Market

Parkinson’s Disease Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Parkinson’s disease companies, including UCB Biopharma SRL, Novartis, Annovis Bio, Supernus Pharmaceuticals, Inc., Britannia Pharmaceutical, Pharma Two B, Mitsubishi Tanabe Pharma (NeuroDerm), AbbVie, Cerevel Therapeutics, LLC, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.